ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Identifying gaps and needs in care for adolescents and young adults with melanoma.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pediatric Melanoma: Emerging Therapies and Ongoing Clinical Trials.Dermatology and therapy · 2026Review
- Quality, Empathy, and Readability of AI Chatbot Responses to the Survivorship Needs of Adolescents and Young Adults With Melanoma: Evaluation Study.JMIR cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeAdolescents and young adults (AYAs, age 15-39 years) with melanoma have needs unique from pediatric or adult populations due to interference with developmental milestones. This study aims to assess the needs of AYA melanoma patients using the Needs Assessment and Service Bridge (NA-SB) questionnaire.
methodsA REDCap survey based on the AYA NA-SB was distributed via email, social media, newsletters, and conferences between August to October 2024. Data were reported for the overall population and analyzed by sex, treatment phase, and exposure to immune checkpoint blockers (ICBs).
resultsOne hundred fifty-two patients participated in the survey. Male and female AYAs had different need profiles, with the males expressing greater need in understanding the role of genetics in diagnosis (51.5% vs. 33.9%, p = 0.019) and the sexual side effects of treatment (38.3% vs. 16.6%, p = 0.016) and the females reporting greater needs in understanding their disease status (71.3% vs. 48.5%, p = 0.003). AYAs on active treatment reported greater needs than those who completed treatment in managing work and life during treatment (55.5% vs. 27.1%, p = 0.03), being equipped to cope with diagnosis (42.8% vs. 25%, p = 0.029), and managing the emotional side effects of treatment (62% vs. 29.5%, p = 0.002). AYAs treated with ICBs had greater needs in managing long-term side effects of treatment (70.8% vs. 31.6%, p = 0.0005), pain management (30.6% vs. 11.6%, p = 0.01), and the physical side effects of treatment (36.7% vs. 16.5%, p = 0.021).
conclusionAYA melanoma patients express unique needs based on sex, treatment phase, and type of systemic therapy. Assessing patient needs and connecting AYAs to relevant supportive services may help mitigate unique challenges encountered during melanoma treatment and in post-treatment survivorship.
Indexed as
Identifiers
41057735What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.